Literature DB >> 9284626

[Vitreous surgery for macular hole followed membrane peeling].

N Tachi1, Y Hashimoto, M Kondo, K Atsumi, N Ogino.   

Abstract

We performed vitreous surgery for macular holes following membrane peeling. The cases were five eyes of five females aged 42 to 67 years at the time of membrane peeling, out of 441 eyes of 414 patients who underwent membrane peeling. One eye had secondary epiretinal membrane combined with ocular sarcoidosis, two eyes had idiopathic epiretinal membrane, and two eyes had idiopathic vitreoretinal traction syndrome. The presumed interval from membrane peeling to macular hole formation was 5 to 90 months (average 14 months). For treatment of the macular holes, membrane peeling and SF6 gas tamponade were performed. In four eyes of the five eyes, the macular hole was closed. In the remaining eye, removal of the retinal pigment epithelium from the base of macular hole and application of fibrin glue were used in addition to SF6 gas tamponade, but the macular hole was not closed. The follow-up term was 10-24 months (average 17.6 months). Geometrical mean visual acuity was 0.34 before membrane peeling, 0.94 at maximum after membrane peeling, 0.19 after macular hole formation, 0.51 at maximum after macular hole surgery, and 0.44 at the final visit.

Entities:  

Mesh:

Year:  1997        PMID: 9284626

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  2 in total

1.  Use of coronal simultaneous optical coherence tomography/scanning laser ophthalmoscopy to demonstrate cystoid macular edema secondary to extrafoveal retinal hole.

Authors:  Igor Kozak; Dirk-Uwe Bartsch; William R Freeman
Journal:  Retin Cases Brief Rep       Date:  2008

2.  Comparison of 27-gauge versus 25-gauge vitrectomy results in patients with epiretinal membrane: 6-month follow-up.

Authors:  Wojciech Lubiński; Wojciech Gosławski; Karolina Podborączyńska-Jodko; Maciej Mularczyk; Michał Post
Journal:  Int Ophthalmol       Date:  2020-01-19       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.